BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• FDA

  Eli Lilly’s CYRAMZA (ramucirumab) Receives Third FDA Approval

  December 18, 2014

   · 

  21 min read
• Business

  Chimerix, Inc. Appoints Ronald C. Renaud, Jr. To Board Of Directors

  December 18, 2014

   · 

  3 min read
• Business

  Dr. Michael A Ross, MD, Appointed As CEO Of Euclid Systems Corporation

  December 18, 2014

   · 

  2 min read
• Business

  Chimerix, Inc. And ContraVir Pharmaceuticals Establish Strategic Collaboration For Antiviral Drug Candidate CMX157

  December 18, 2014

   · 

  5 min read
• Drug Development

  Biocryst Pharmaceuticals Initiates Opus-2: A Clinical Trial Of BCX4161 In Patients With Hereditary Angioedema

  December 18, 2014

   · 

  5 min read
• BioMidwest

  Oasis Health Products, Inc. Announces Completion Of Stability Testing On Itonis, Inc.'s EMESYL Nausea Relief

  December 18, 2014

   · 

  1 min read
• Drug Development

  Fate Therapeutics Announces Interim Data From Ongoing Phase 2 PUMA Study

  December 18, 2014

   · 

  13 min read
• Trillium Therapeutics Inc. To List Common Shares On The NASDAQ Capital Market Under The Symbol TRIL

  December 18, 2014

   · 

  2 min read
• Pharm Country

  Anavex To Present At Biotech Showcase 2015 In San Francisco

  December 18, 2014

   · 

  3 min read
• France Biotech Presents The Results Of Its Twelfth Annual Survey, « Panorama Of The Life Sciences® »

  December 18, 2014

   · 

  1 min read